Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renew Pharmaceuticals, commonly known as Renew Pharms, is a specialty pharmaceutical company headquartered in Athlone, Ireland, and a subsidiary of the Singapore-listed Ultragreen.ai (SGX: ULG). The company is a global leader in the production and distribution of Indocyanine Green (ICG), a diagnostic dye used extensively in fluorescence-guided surgery (FGS) to visualize tissue perfusion and lymphatic flow in real-time. Renew Pharms markets its products under the brand names IC-Green in North America and Verdye in the EMEA region through its associated business, Diagnostic Green. The company is actively expanding its portfolio into surgical AI and advanced imaging technologies through strategic investments in firms like Perfusion Tech and Ferronova. Renew Pharmaceuticals aims to establish fluorescence imaging as the global standard for tissue visualization to improve surgical precision and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renew Pharms.